Data management in oncology clinical trials features multiple complexities, and choosing the right EDC system is essential.

Mayo Clinic Labs CEO explains how healthcare's data revolution reshapes clinical diagnostics and accelerates medical research.

Healthcare data analytics leader MedeAnalytics and agentic AI innovator Basys.ai announced a strategic partnership that will benefit health payers.

Data show deep, durable responses in the 50 million cell dose level cohort; initial data suggest substantial early improvement in three patients dosed with 100 million cellsAll patients show deep ...

The ASH oral presentation today reports data from the ongoing dose escalation and dose expansion parts of the CARDINAL study of TERN-701 in patients with previously treated CML. As of the September 13 ...

Cullinan Management ( ($CGEM) ) has issued an announcement. On December 8, 2025, Cullinan Therapeutics presented updated clinical data from its ...

In today’s ACT Brief, we examine how the FDA’s CNPV Program is reshaping operational planning and accelerated submission ...

Trinity Health Chief Health Informatics Officer Murielle Beene shares how health informaticists are approaching artificial ...

The technology is designed to help thousands of diabetic and hypertensive patients achieve control over their conditions, ...

For Phase III trial planning, two suggestions may have merit. Include sizeable subpopulations that payers cannot easily ...

AI-driven discovery, EHR-based real-world evidence, and synthetic patient modeling are rapidly reshaping drug repurposing, reducing development timelines, expanding therapeutic applications, and ...

Altimmune, Inc. nears key MASH data for pemvidutide—learn investor risks, potential rewards, and what the upcoming results ...